Neuroendocrine Tumor Market Size, Share, Growth, Research and Forecast 2019-2025
The global neuroendocrine tumor market is projected to grow at a CAGR of around 10% during the forecast period. The market is studied on the basis of treatment type, indication, and end-user. Amongst the indication, the global neuroendocrine tumor market is segmented into the lungs, pancreas, gastrointestinal, and others. The gastrointestinal segment holds a significant share in the market. The segmental growth is attributed to the increased incidences of gastrointestinal diseases such as colon cancer, tumor in the intestine, and many others. The rising prevalence of several gastrointestinal diseases has been recorded globally. As per WHO, gastric cancer has been the fifth most common cancer globally in which malignant (cancer) cells form in the lining of the stomach.A full report of Global Neuroendocrine Tumor Market is available at: https://www.omrglobal.com/industry-reports/neuroendocrine-tumor-market
Smoking and ulcer are some major factors leading to gastric cancer. Additionally, other factors including age factor, diet, and stomach disease such as gastrointestinal reflux disease (GERD) can increase the risk of developing gastric cancer. Symptoms of gastric cancer include indigestion and stomach discomfort or pain. It has been noted that about 6 out of 10 people with the age of 65 years or older are expected to be diagnosed with gastric cancer. Additionally, the average risk of a person developing stomach cancer in their lifetime is about 1 in 111.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/neuroendocrine-tumor-market
In the US, more than 26,240 incidences of gastric cancer were recorded in 2018 which is about 15% of all new cancer cases, according to the National Cancer Institute. The situations are more severe in Asian countries such as Japan and China. For instance, Japan has around 132,800 cases of stomach cancer in 2017. Similar trends were observed in China as around 498,000 gastric cancer deaths were recorded. Such an increasing number of cases increase the demand for better treatment options, which in turn, drive the growth of the global neuroendocrine tumor market.
Current Market Trends Covered in the Market Report:
o Increased investments by the government and private organizations towards the introduction and development of various treatment methods and drugs is positively affecting the neuroendocrine tumor industry growth during the forecast period
o Somatostatin Analogs (SSA)segment will account for a significant share in the neuroendocrine tumor market
o Novel drug development and several product pipelines are the key strategies of the key players
o North America to hold a considerable share in the market across the globe
Global Neuroendocrine Tumor Market - Segmentation
By Treatment Type
o Somatostatin Analogs (SSA)
o Targeted Therapy
o Chemotherapy
o Others
By Indication
o Lungs
o Pancreas
o Gastrointestinal
o Others
By End-User
o Hospital& Clinics
o Others
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/neuroendocrine-tumor-market
Global Neuroendocrine Tumor Market - Segmentation by Region
North America
o United States
o Canada
Europe
o Germany
o United Kingdom
o France
o Spain
o Italy
o Rest of Europe
Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific
Rest of the World
o Middle East & Africa
o Latin America
Company Profiles
o AVEO Pharmaceuticals Inc.
o Boehringer Ingelheim International GmbH
o Bristol-Myers Squibb Co.
o Dauntless Pharmaceuticals, Inc.
o Eli Lilly & Co.
o Exelixis, Inc.
o F. Hoffmann-La Roche Ltd.
o Hutchison MediTechLtd.
o Ipsen Group
o Mateon Therapeutics, Inc.
o Novartis International AG
o Pfizer Inc.
o Progenics Pharmaceuticals, Inc.
o Tarveda Therapeutics, Inc.
o Teva Pharmaceutical Industries, Ltd.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Tumor Market Size, Share, Growth, Research and Forecast 2019-2025 here
News-ID: 2037340 • Views: …
More Releases from Orion Market Research
Car Electronics Accessories and Communication Market Size, Share, Trends, Demand …
Car electronics accessories and communication market is anticipated to grow at a considerable CAGR of 5.6% during the forecast period. Rising demand for advanced car accessories and communication systems with online configuration is augmenting the market growth. As technological advancements continue to rise, companies are strengthening their core technological capabilities and focusing on technical innovation in their in-car electronics accessories. Due to this, consumers are increasingly inclined toward smart and next-generation…
Sorbitol Market Is Expected to Exhibit Significant Growth Over 2031 / Cargill In …
Sorbitol Market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period. Crystal sorbitol is widely utilized as a food additive for producing frozen raw fish, roasted fish fillet, polydextrose (soluble dietary fiber), mint tablets, chewing gum, shrimp ball, and dried squid thread. It's also used in a variety of frozen aquatic products and sugar-free snacks. The growing demand for application products, primarily in meat products…
Biopesticides Market is Likely to Increase at a Significantly High CAGR during F …
Biopesticides Market is anticipated to grow with a significant CAGR of around 12% during the forecast period. Biopesticides products usually fight only their intended pests and don't affect any non-target species such as other insects, birds, and mammals, unlike the chemical pesticides which will drive the adoption of the biopesticides. Hence, the increased adoption of the biopesticides product will propel the biopesticides industry during the forecast period. In addition to…
European Automotive Data Logger Market Size 2023: Global Share, Industry And Rep …
The European automotive data logger market is anticipated to grow at a significant growth rate of 5.7% during the forecast period. European Automotive Data Logger Market report provides us with a complete outlook on thorough assessment of thorough data about vital feature of the global industry related to market size, revenue, development and market sales. This study report captures regulatory concerns and entry barriers that greatly affect the market…
More Releases for Neuroendocrine
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Neuroendocrine Carcinoma Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Neuroendocrine Carcinoma Market will expand with a CAGR value of 10.6 percent from 2021 to 2026. Owing to a rise in the prevalence of neuroendocrine tumors (NETs) across the globe, the global neuroendocrine carcinoma market will grow rapidly during 2021-2026 forecast period.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-neuroendocrine-carcinoma-market-3109
By Site (Gastrointestinal, Lung, Brain, Pancreas, and Others), By Therapy (Surgery, Radiation Therapy, and Chemotherapy), By…
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Gro …
The market report titled ‘Global Neuroendocrine Cancer Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of…
Neuroendocrine Carcinoma Market Analysis & Key Trends 2020
A neuroendocrine tumor is a kind of tumor that begins in the hormone producing cells of the neuroendocrine system that is made up of the endocrine system and nervous system. Hormones producing neuroendocrine cells have a structure similar to neurons and produce hormones like endocrine cells. These cells are found throughout the body in organs such as intestines, kidneys, lungs and stomach and perform functions such as controlling the speed…
Neuroendocrine Tumors Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.
Neuroendocrine tumor begins in the hormone-producing cells of the body's neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part…
Neuroendocrine Tumors Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.
Neuroendocrine tumor begins in the hormone-producing cells of the body's neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part…